The go-live is transforming how clinical staff examine crucial patient images.

CDC researchers are estimating that asymptomatic COVID-19 carriers account for at least half of all community transmissions. This includes carriers who never develop symptoms as well as those who later do.

“The key for the ultimate adoption of this new procedure will be further refinements of the technology to ensure reliability and safety," University of Virginia Health researchers explained.

“The differences in the findings are extremely important,” one researcher said. 

Researchers explored data from more than 11,000 patients.

AI researchers and developers across the U.S. received a powerful if overshadowed shot in the arm on New Year’s Day.

The modality also beat out all other tests, including EKG, echocardiograms and clinical exams, at identifying athletes with muscle heart inflammation, experts reported in Circulation.

Most current approaches are complex and don't specifically discuss imaging, researchers explained in an opinion piece published recently in JACR.

The new treatment strategy shows significant potential. A full evaluation was published in Microsystems & Nanoengineering.

The FDA has cleared UK-based Ultromics to sell an AI-powered tool for diagnosing coronary artery disease (CAD) on echocardiograms.